Related Experiment Videos
Cyclosporine
Drug Intelligence & Clinical Pharmacy
|February 1, 1985
Summary
Cyclosporine, an immunosuppressant, improves patient and graft survival in organ transplantation. Careful monitoring of cyclosporine blood levels is crucial for managing transplant patients and minimizing adverse effects.
Area of Science:
- Immunology
- Pharmacology
- Transplantation Medicine
Background:
- Cyclosporine is a vital immunosuppressant for preventing organ transplant rejection.
- It selectively suppresses T-lymphocyte function without causing myelosuppression.
- Its use has significantly improved outcomes in kidney, heart, and liver transplantation.
Purpose of the Study:
- To review the role of cyclosporine in organ transplantation.
- To highlight its efficacy in improving patient and graft survival.
- To discuss its pharmacokinetic variability, adverse effects, and monitoring requirements.
Main Methods:
- Review of clinical studies and pharmacologic data on cyclosporine.
- Comparison of cyclosporine therapy with conventional immunosuppressants.
- Analysis of adverse effects and dosage guidelines.
Main Results:
- Cyclosporine significantly enhances patient and graft survival rates post-transplantation.
- Patients on cyclosporine experience fewer complications compared to conventional therapies.
- Adverse effects such as nephrotoxicity and hepatotoxicity are reversible with dose adjustment.
Conclusions:
- Cyclosporine has revolutionized organ transplantation, establishing it as a viable therapeutic option.
- Individualized dosing and therapeutic drug monitoring are essential for optimal outcomes.
- Continued research and monitoring are necessary to manage cyclosporine's side effects effectively.